Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:57:09 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:FENC from 2023-05-07 to 2024-05-06 - 16 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-21 06:00U:FENCNews ReleaseFennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
2024-03-19 06:01U:FENCNews ReleaseFennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
2024-03-17 21:00U:FENCNews ReleaseFennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
2024-02-29 07:04U:FENCNews ReleaseFennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
2024-02-01 05:55U:FENCNews ReleaseFDA Issues Reminder of Non-Substitution of PEDMARK ‚ ® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
2023-12-05 05:55U:FENCNews ReleaseFennec Announces Incremental $5 Million Investment from Petrichor
2023-11-09 16:50U:FENCNews ReleaseFennec Pharmaceuticals to Participate in Upcoming Investor Conferences
2023-11-06 05:59U:FENCNews ReleaseFennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
2023-10-30 06:45U:FENCNews ReleaseFennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023
2023-09-07 05:59U:FENCNews ReleaseFennec Pharmaceuticals to Participate in Upcoming Investor Conferences
2023-08-03 05:59U:FENCNews ReleaseFennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
2023-07-31 05:30U:FENCNews ReleaseFennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023
2023-06-12 17:00U:FENCNews ReleaseFennec Announces Results of Annual Meeting
2023-06-06 05:44U:FENCNews ReleaseFennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi ¢ „ ¢ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
2023-05-11 06:01U:FENCNews ReleaseFennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
2023-05-08 06:15U:FENCNews ReleaseFennec Pharmaceuticals to Report First Quarter 2023 Financial Results on ‚  May 11, 2023